--- 6-months’ therapy months’ therapy Supplementary Figure 1.

Slides:



Advertisements
Similar presentations
BODY MASS INDEX (B.M.I.).
Advertisements

Obesity Trends - U.S. Adults (1985 – 2009) Definitions: Obesity: having a very high amount of body fat in relation to lean body mass, or Body Mass Index.
P449. p450 Figure 15-1 p451 Figure 15-2 p453 Figure 15-2a p453.
P247. Figure 9-1 p248 Figure 9-2 p251 p251 Figure 9-3 p253.
Click 98 bmi 1,75 kg m 98 bmi 1,75 kg m 32 Applet for calculation of body mass index.
Body Mass Index and Calorie. Body Mass Index Body Mass Index, or BMI, is a tool that helps you measure the amount of body fat you have based on your height.
WHAT IS BMI? BMI BODY MASS INDEX- BASED ON HEIGHT AND WEIGHT TO DETERMINE AMOUNT OF FAT AN INDIVIDUAL HAS OBESE BMI > 30.
Dietary Intervention Prevents Dyslipidemia Associated with Highly Active Antiretroviral Therapy in HIV-1- infected Individuals: A Randomized Trial Rosmeri.
Allocated to IV arm (n=85) Allocated to HIA arm (n=86) Started allocated intervention (n=83) Did not receive allocated therapy (n=2) - Refusal (n=2) Started.
Weight times length Weight times height Length times height.
How to Calculate Your Body Mass Index (BMI)
The impact of obesity on drug prescribing in primary care BJGP Volume 55(519): October 1, 2005 ©2005 by British Journal of General Practice.
ICa i e sr lo. ONE Design Statement Nowadays, a lot people wants to be healthy or loss weight. In project 1, I decided to do a Calories calculator for.
Association between Weight Gain and Symptoms of Gastroesophageal Reflux in the General Population Enrique Rey, Cristina Moreno-Elola-Olaso, Fernando Rodriguez.
Division of Plastic Surgery University of Puerto Rico Norma I. Cruz, MD Nothing to disclose.
Date of download: 6/21/2016 From: Psychological and Behavioral Interventions for Managing Insomnia Disorder: An Evidence Report for a Clinical Practice.
Date of download: 6/21/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Prediction of Erectile Function Following Treatment.
Date of download: 6/25/2016 Copyright © 2016 American Medical Association. All rights reserved. From: BNP-Guided vs Symptom-Guided Heart Failure Therapy:
Supplementary Appendix Thrombotic Risk Scores % of Patients Risk Categories Low Risk (n=3491) Intermediate Risk (n=2806)
Date of download: 9/17/2016 From: Dose Response to Vitamin D Supplementation in Postmenopausal Women: A Randomized Trial Ann Intern Med. 2012;156(6):
USRDS USRDS 2002 adr Incident counts by initial modality figure 7.1 patients age 19 years & younger.
Lacto-ovo vegetarian group
How to Calculate Your Body Mass Index (BMI)
From ESH 2016 | POS 4C: A. Power, MD
Supplemental Figure 1 A B C D E F
Figure 1 CONSORT flow diagram of the progress of participants through the trial. STM=soft tissue massage. From: Effectiveness of Soft Tissue Massage for.
Copyright © 2009 American Medical Association. All rights reserved.
Figure 2 Top panel shows mean (SE) differences in near-final height (cm) (n = 71) in the AI, GH, and AI/GH groups regardless of length of treatment (n.
Copyright © 2008 American Medical Association. All rights reserved.
Copyright © 2004 American Medical Association. All rights reserved.
Figure 1. Flow diagram indicating progress of subjects through the study and stage at which subjects were lost to follow-up. A=mid-range mobilization,
Chart for estimating body mass index (BMI)
Without insulin therapy (n = 14)
The American Journal of Occupational Therapy
Testosterone treatment improves body composition and sexual function in men with COPD, in a 6-month randomized controlled trial  J Svartberg, U Aasebø,
Figure 3. Hypothalamic–Pituitary–Adrenal (HPA)-axis functioning moderates crime exposure: regions of significance on X (crime). The lines represent two.
Copyright © 2015 by the American Osteopathic Association.
Supplementary material
Copyright © 2011 American Medical Association. All rights reserved.
HSC 4030 Enthusiastic Study/snaptutorial.com
Magnitude and Kinetics of Decrease in Liver Stiffness After Antiviral Therapy in Patients With Chronic Hepatitis C: A Systematic Review and Meta-analysis 
Volume 15, Issue 4, Pages (July 2015)
Reduction of C-reactive protein levels through use of a multivitamin
Maternal underweight and child growth and development
Joshua A. Bell et al. JACC 2018;72:
Joshua A. Bell et al. JACC 2018;72:
Table 1. General Characteristics of the Study Subjects
C. Motteram, B. Vollenhoven, N. Hope, T. Osianlis, L.J. Rombauts 
Jaime Céspedes, MD, German Briceño, MD, MSc, Michael E
TIERING ACTIVITY FITNESS.
Ready-to-use food supplement, with or without arginine and citrulline, with daily chloroquine in Tanzanian children with sickle-cell disease: a double-blind,
ΔBMI SDS of all boys and girls in Fukushima Prefecture
Screening, enrollment, and randomization of study participants (BMI, body mass index; CTG, conventional therapy group; HbA1c, glycated hemoglobin; HDL-C,
The BMI SDS of all boys and girls in Fukushima Prefecture
Glycaemic management in patients with diabetes in hospital
Connie W. Tsao et al. JCHF 2016;4:
Supplementary Figure S4
The effects of metformin with lifestyle therapy in polycystic ovary syndrome: a randomized double-blind study  Gwinnett Ladson, M.D., William C. Dodson,
Comparison between groups
Nat. Rev. Cardiol. doi: /nrcardio
Volume 156, Issue 5, Pages (April 2019)
Student Name Student College Student Department Submission No:
RECORD Study: Enrollment and Outcomes
Effects of metformin on body mass index, menstrual cyclicity, and ovulation induction in women with polycystic ovary syndrome  Derek A Haas, M.D., Bruce.
Patient education with or without manual therapy compared to a control group in patients with osteoarthritis of the hip. A proof-of-principle three-arm.
Figure:
The Chemical Biology of Human Vitamins
RANDOM NUMBERS SET # 1:
Previous | index | next Figure_19_01.
Obesity Trends Among U.S. Adults Between 1985 and 2010
Presentation transcript:

--- 6-months’ therapy --- 3-months’ therapy Supplementary Figure 1. Onset At 12-months At 24-months Randomization After intervention Height SDS --- 6-months’ therapy --- 3-months’ therapy P 0.96 0.96 0.83 0.37 0.78 Onset At 12-months At 24-months Randomization After intervention Supplementary Figure 1. Body mass index SDS --- 6-months’ therapy --- 3-months’ therapy P 0.82 0.96 0.60 0.87 0.96